The landscape of drug/device development is evolving rapidly. Let us find a solution that best fits your needs.
Successful Biotech/Pharma startups are among the highest ROI industries. Leverage RMBio’s scientific expertise to support your scientific and technical assessments to make informed decisions.
Investment Firms (Private Equity, Institutional Investors)
-
Due Diligence & Investment Support
Technical due diligence on emerging biotech/pharma startups
Risk assessment of biomedical assets, including safety and regulatory risks
Evaluation of IP and patent landscape for biotech and pharma companies
Market potential analysis for biomedical devices, drugs, and nanotherapeutics
Assessment of clinical trial feasibility and scalability of biotech innovations
-
Portfolio & Risk Management
Pipeline analysis of biotech companies for long-term investment
Assessment of regulatory and market risks for pharma/biotech investments
Evaluation of biotech IPOs and M&A opportunities
Predictive analysis of success rates based on preclinical and clinical data
-
Technology & Scientific Validation
Scientific vetting of technology claims made by biotech startups
Analysis of preclinical and clinical trial data for investment decisions
Evaluation of competitive advantages of medical devices, implants, and therapeutics
